SHARLENE DALEY: Open Payments
NPI 1669845889 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,326 in 123 payments from 15 companies in 2025. Trend: 2023 $1,261 · 2024 $3,062 · 2025 $2,326
Food & beverage: $2,326
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 29 | $358 |
| Axsome Therapeutics, Inc. | 10 | $315 |
| Neurocrine BioSciences, Inc. | 7 | $214 |
| Supernus Pharmaceuticals, Inc. | 14 | $199 |
| Janssen Pharmaceuticals, Inc | 6 | $190 |
| Vanda Pharmaceuticals Inc. | 7 | $187 |
| Otsuka America Pharmaceutical, Inc. | 14 | $178 |
| ABBVIE INC. | 10 | $161 |
| Alkermes, Inc. | 6 | $157 |
| Almatica Pharma LLC | 5 | $91 |
Products named: CAPLYTA, Auvelity, INGREZZA, Qelbree, INVEGA SUSTENNA, REXULTI, VRAYLAR, ARISTADA.
Industry payments across FL — which companies pay providers there.
